-
The official briefing is coming! The State Drug Administration disclosed the latest progress in the development of the new crown vaccine
Time of Update: 2021-02-24
Pharma Network February 19 - February 19, the Supreme People's Procuratorate, the State Administration of Market Supervision and Administration and the State Drug Administration, jointly issued 15 imp
-
Guangxi Medical Complex: Unified procurement of pharmaceutical supplies unified payment
Time of Update: 2021-02-24
Unified procurement unified payment, the basic medical device procurement model changes "notice" first clearly, the current measures referred to as the medical association including but not limited to urban medical groups, county medical and health community (hereinafter referred to as county medical community), three-two medical associations, specialized alliances and telemedicanic collaboration network.
-
45 over 100 million varieties dominate the Chinese medicine market! 5 exclusive injections killed...
Time of Update: 2021-02-24
Pharmaceutical Network February 20, before the Spring Festival, "on the promotion of drug centralized band procurement normalized institutionalization of the views" issued, which will clearly explore
-
A new generation of antibody-coupled drugs is eligible for FDA priority review
Time of Update: 2021-02-24
if BCG is ineffective or if the patient needs to receive BCG for a long time, the recommended treatment is a complete removal of the bladder.
Vicineum is a next-generation ADC drug developed using Sesen Bio's proprietary targeted protein therapy platform.
-
National mining press the accelerator key, where does generic drugs go from here?
Time of Update: 2021-02-24
Medicine Network February 20th, before the New Year, the National Health Insurance Administration to the people of the country sent a new annual gift. La Month 28 (February 8), the fourth batch of nat
-
The State Drug Administration revised the six-flavored yellow preparation instruction manual
Time of Update: 2021-02-24
Annex Annex 2 Revised requirements for over-the-counter prescription drugs for six-flavored yellow preparations Should include: Monitoring data show that six-flavored yellow preparations have diarrhea, abdominal pain, bloating, nausea, vomiting, gastrointestinal discomfort, loss of appetite, constipation, itching, rash, headache, palpitations, allergies and other adverse reactions reported.
-
State Drug Administration: The six-flavored yellow preparation instructions for a unified revision
Time of Update: 2021-02-24
the announcement stressed that the provincial drug supervision and administration departments should urge the drug market license holders of the above-mentioned drugs in the administrative area to do a good job in accordance with the requirements of the corresponding manual revision and labeling, manual replacement work, the violation of the law and strict investigation and punishment.
-
The study revealed the exact cause of death of a python in ancient Egypt 3,600 years ago
Time of Update: 2021-02-24
CAIRO, Feb. 17 (Xinhua Wu Dani Marwa Yahya) Egyptian archaeologists and medical experts published a study on the 17th showed that about 3,600 years ago, the ancient Egyptian 17th Dynasty python Segenenla should have been killed in the battle with the Hexos, whose head wounds were cleverly hidden by mummy makers.
-
Is it up or down? The latest salaries of practicing pharmacists are announced
Time of Update: 2021-02-24
to this, there have been six years of working first-line practicing pharmacists to give us feedback, their northern provincial capital city, the average monthly income of the local 6k-7k bar, their monthly salary is only 4k.
, in addition to working cities, practicing pharmacists work in pharmacies, pharmaceutical manufacturers and pharmaceutical wholesale enterprises will have different wages.
-
These 13 new drugs are on: Hengrui, Haizheng, and Huang...
Time of Update: 2021-02-24
China's public medical institutions terminal blood lipid drug sales source: Minet China's public medical institutions terminal competition pattern Haize mebu tablets are the first Haizheng Pharmaceuticals to declare the listing of a new class of drugs, its research and development investment has reached 280 million yuan, some brokerages predict that its approval is expected to become a billion-class heavy varieties.
-
The first in the country! Anhui introduced a DIP guidance program for 7 cities pilot
Time of Update: 2021-02-24
Medical Network February 9, 2021 - February 1, 2021, Anhui Provincial Health Security Bureau, Anhui Provincial Health And Health Committee, Anhui Provincial Finance Department on the issuance of "Anhu
-
3 days 3 license-in super 2.8 billion traditional pharmaceutical giant innovation transformation into the era of rapid growth
Time of Update: 2021-02-24
February 16, Qilu Pharmaceuticals signed a cooperation agreement with Cend Therapeutics, a U.S. biotech company, to obtain exclusive rights to Cend's new cancer drug in Greater China for up to $235 million.
-
The UK has approved volunteers to actively infect with the new coronavirus to test the vaccine
Time of Update: 2021-02-24
, on the other hand, the Human Challenge trial could also be used to study vaccines that have been adapted to be more effective against recent new coronavirus variants.
-
By 2021, these Chinese medicines will have to go up in price
Time of Update: 2021-02-24
can be predicted that after the implementation of the 2020 edition of the Pharmacopeia, the price of Chinese herbal medicines will be polarized due to the quality, in line with the pharmacopeia standards of medicinal herbs will have a greater potential for price increases.
-
GE Healthcare cuts 31,000 employees as a whole, or continues to layoffs in 2021
Time of Update: 2021-02-24
, GE's aviation business has taken a number of business actions to address the current adverse environment, including reducing its global workforce by about 25 percent, according to its annual report.
-
Koren, East Sunshine Medicine, It's Sunny... The 12 heavyweights will be approved
Time of Update: 2021-02-24
Table 4: New classification of sodium tablets in Shakuba Qulushatan Source: MED2.0 China Drug Review Database At present, there are 7 domestic enterprises to copy 4 categories of Shakuba Qusaltan sodium tablets to submit the listing application, of which Shanghai Xuantai Haimen Pharmaceuticals first reported production, its listing application in November 2018 by the CDE contractor acceptance, is currently in the second round of information replacement.
-
Biogen gave up the Parkinson's drug cimpanemab
Time of Update: 2021-02-24
2018, Yan Jian outlined the design of phase 2 clinical study SPARK and said the study was the most advanced project in the company's Research Drug Pipeline for Parkinson's disease at the time.
-
Jiangsu Province not listed products without national medical insurance drug code will not be able to declare sunshine procurement
Time of Update: 2021-02-24
april 1, 2021, the national medical insurance drug classification and code published by the provincial platform network products will be displayed in the drug settlement trading system for the transaction subject to be compared.
-
FDA approves new drug extension adaptation for Parkinson's disease
Time of Update: 2021-02-24
from two key, placebo-controlled Phase 3 clinical trials, Gocovri's treatment significantly reduced "off-period" time and movement disorders.
is now the only drug approved for treatment of Parkinson's disease 'off period' and complications of movement disorders.
-
The application for the listing of regenerant biology Terripley single anti-new anti-adhesive disease was accepted
Time of Update: 2021-02-24
On February 18, Junshi Bio announced that the company had received a "notice of acceptance" approved by the State Drug Administration, and that the new adaptation application for Ripley monoantithermal combination chemotherapy for advanced first-line relapsed metastatic nasopharyngeal cancer that had not received systematic treatment was accepted.